Claims for Patent: 7,790,958

Summary for Patent: 7,790,958

Title:	Genomic plant sequences and uses thereof
Abstract:	The present invention discloses rice genomic promoter sequences. The promoters are particularly suited for use in rice and other cereal crops. Methods of modifying, producing, and using the promoters are also disclosed. The invention further discloses compositions, transformed host cells, transgenic plants, and seeds containing the rice genomic promoter sequences, and methods for preparing and using the same.
Inventor(s):	Boukharov; Andrey A. (Chesterfield, MO), Cao; Yongwei (Lexington, MA), Dotson; Stanton B. (Chesterfield, MO), Koshi; Jeffrey M. (Cambridge, MA), Kovalic; David K. (University City, MO), Liu; Jingdong (Ballwin, MO), McIninch; James D. (Burlington, MA), Wu; Wei (St. Louis, MO)
Assignee:	Monsanto Technology LLC (St. Louis, MO)
Application Number:	11/595,983
Patent Claims:	1. A substantially purified nucleic acid molecule having promoter activity comprising a nucleic acid sequence, wherein the nucleic acid sequence: i) comprises the nucleic acid sequence of SEQ ID NO:6042, ii) exhibits a 99% or greater identity to the sequence of SEQ ID NO:6042, or iii) comprises a fragment of SEQ ID NO:6042 that comprises at least 300 contiguous nucleotides of SEQ ID NO: 6042. 2. The nucleic acid molecule of claim 1, wherein the nucleic acid sequence exhibits a 99% or greater identity to the nucleic acid sequence of SEQ ID NO:6042. 3. The nucleic acid molecule of claim 1, wherein the nucleic acid sequence comprises the sequence of SEQ ID NO:6042. 4. The nucleic acid molecule of claim 1, wherein the nucleic acid molecule is operably linked to a heterologous structural nucleic acid sequence. 5. The nucleic acid molecule of claim 4, wherein the structural nucleic acid sequence encodes a protein selected from the group consisting of a yield protein, a stress resistance protein, a developmental control protein, a tissue differentiation protein, a meristem protein, an environmentally responsive protein, a senescence protein, a hormone responsive protein, an abscission protein, a source protein, a sink protein, a flower control protein, a seed protein, an herbicide resistance protein, a disease resistance protein, a fatty acid biosynthetic enzyme, a tocopherol biosynthetic enzyme, an amino acid biosynthetic enzyme, and an insecticidal protein. 6. The nucleic acid molecule of claim 1, wherein the nucleic acid molecule further comprises one or more cis-acting nucleic acid elements. 7. The nucleic acid molecule of claim 1, wherein the nucleic acid molecule further comprises a 5' leader sequence selected from the group consisting of dSSU 5', PetHSP70 5', and GmHSP 17.9 5'. 8. The nucleic acid molecule of claim 1, wherein the nucleic acid molecule further comprises a 3' untranslated region. 9. The nucleic acid molecule of claim 8, wherein the 3' untranslated region is selected from the group consisting of NOS 3', E9 3', ADR 12 3', 7Sa 3', 11 S 3', and albumin 3'. 10. The nucleic acid molecule of claim 4, wherein the nucleic acid molecule further comprises an intron that is heterologous with respect to the structural nucleic acid sequence. 11. The nucleic acid molecule of claim 10, wherein the intron is selected from the group consisting of a rice actin intron and a corn HSP70 intron. 12. The nucleic acid molecule of claim 1, wherein said substantially purified nucleic acid molecule is operably linked to a heterologous nucleic acid molecule and said heterologous nucleic acid molecule codes for an mRNA that is complementary to an mRNA that is present in a cell. 13. A transgenic plant containing a nucleic acid molecule that comprises in the 5' to 3' direction: a nucleic acid sequence having promoter activity that: i) comprises the nucleic acid sequence of SEQ ID NO:6042, ii) exhibits a 99% or greater identity to the sequence of SEQ ID NO:6042, or iii) comprises a fragment of SEQ ID NO:6042 that comprises at least 300 contiguous nucleotides of SEQ ID NO: 6042; operably linked to a structural nucleic acid sequence; wherein the nucleic acid sequence is heterologous with respect to the structural nucleic acid sequence. 14. The transgenic plant of claim 13, wherein the nucleic acid sequence is 99% identical to the nucleic acid sequence of SEQ ID NO:6042. 15. The transgenic plant of claim 13, wherein the nucleic acid sequence comprises the nucleic acid sequence of SEQ ID NO:6042. 16. The transgenic plant of claim 13, wherein the structural nucleic acid sequence encodes a protein selected from the group consisting of a yield protein, a stress resistance protein, a developmental control protein, a tissue differentiation protein, a meristem protein, an environmentally responsive protein, a senescence protein, a hormone responsive protein, an abscission protein, a source protein, a sink protein, a flower control protein, a seed protein, an herbicide resistance protein, a disease resistance protein, a fatty acid biosynthetic enzyme, a tocopherol biosynthetic enzyme, an amino acid biosynthetic enzyme, and an insecticidal protein. 17. The transgenic plant of claim 13, wherein the nucleic acid molecule further comprises one or more cis-acting nucleic acid elements. 18. The transgenic plant of claim 13, wherein the nucleic acid molecule further comprises a 5' leader sequence selected from the group consisting of dSSU 5', PetHSP70 5', and GmHSP17.9 5'. 19. The transgenic plant of claim 13, wherein the nucleic acid molecule further comprises a 3' untranslated region. 20. The transgenic plant of claim 19, wherein the 3' untranslated region is selected from the group consisting of NOS 3', E9 3', ADR12 3', 7Sa 3', 11 S 3', and albumin 3'. 21. The transgenic plant of claim 13, wherein the nucleic acid molecule further comprises an intron that is heterologous with respect to the structural nucleic acid sequence. 22. The transgenic plant of claim 21, wherein the intron is selected from the group consisting of a rice actin intron and a corn HSP70 intron. 23. The transgenic plant of claim 13, wherein the plant is rice, sorghum, maize, barley, or wheat. 24. The transgenic plant of claim 13, wherein said structural nucleic acid molecule encodes an mRNA that is complementary to an mRNA that is present in said transgenic plant. 25. A seed from the transgenic plant of claim 13 comprising a nucleic acid molecule that comprises in the 5' to 3' direction: a nucleic acid sequence having promoter activity that: i) comprises the nucleic acid sequence of SEQ ID NO:6042, ii) exhibits a 99% or greater identity to the sequence of SEQ ID NO:6042, or iii) comprises a fragment of SEQ ID NO:6042 that comprises at least 300 contiguous nucleotides of SEQ ID NO: 6042; operably linked to a structural nucleic acid sequence; wherein the nucleic acid sequence is heterologous with respect to the structural nucleic acid sequence. 26. A fertile transgenic plant from the seed of claim 25. 27. A method of transforming a host cell, said method comprising: a) providing a nucleic acid molecule that comprises in the 5' to 3' direction: a nucleic acid sequence having promoter activity that: i) comprises the nucleic acid sequence of SEQ ID NO:6042, ii) exhibits a 99% or greater identity to the sequence of SEQ ID NO:6042; or iii) comprises a fragment of SEQ ID NO:6042 that comprises at least 300 contiguous nucleotides of SEQ ID NO: 6042; operably linked to a structural nucleic acid sequence; and b) transforming said host cell with the nucleic acid molecule. 28. The method of claim 27, wherein the nucleic acid sequence exhibits a 99% or greater identity to the nucleic acid sequence of SEQ ID NO: 6042. 29. The method of claim 28, wherein the nucleic acid sequence comprises the sequence of SEQ ID NO: 6042. 30. A substantially purified nucleic acid molecule having promoter activity comprising the nucleic acid sequence of SEQ ID NO: 6042 or the complement thereof.

Details for Patent 7,790,958

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2019-07-20
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2019-07-20
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2019-07-20